Market revenue in 2023 | USD 4.3 million |
Market revenue in 2030 | USD 26.7 million |
Growth rate | 29.8% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 53.49% in 2023. Horizon Databook has segmented the Mexico artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is making rapid headway in the field of AI. The country has a young talented labor force and is one of the leading countries to announce AI strategies. Increasing prevalence of chronic diseases in the country and growing need to control drug discovery & development costs are factors anticipated to drive the country’s adoption of AI in drug discovery.
According to the International Diabetes Federation, the prevalence of diabetes among adults is 15.2%, accounting for around 12,805,200 patients in the country. Mexico also has a promising group of startups working to discover new digital solutions for challenges at local and national levels.
The country has a strong educational community, which is expected to prosper with the right assistance. Local governments are already dedicated to working with civil society on AI implementation. These factors are anticipated to bolster Mexico’s adoption of AI in drug discovery over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Mexico artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account